United States: That is because respiratory illnesses such as flu, cold, COVID-19, and RSV are circulating vigorously in the United States today. According to CDC, these illnesses are at “high” levels in the United States of America, across the nation.
New Hampshire has “very high” activity, and another 11 states including Arizona, Texas, and Tennessee are in the “high” category of these sicknesses.
At the same time, 29 states are mentioned as having moderate level of activity while the rest states contain low level of activity.
Also, the rate of COVID-19, seasonal flu and RSV varies on ground more across nation’s HEALTH facility admission, and the positivity ratio of tests of COVID-19, seasonal flu or RSV, enhanced by the CDC.
According to reports from the CDC up to week 51, which ended 21 December, flu has affected not less than 3.1 million individuals leading to hospitalization of 37, 000 individuals and cause 1500 deaths.This occurred in the week ending December 21 and brought the total previous pediatric death reports to nine this season and the 2024/25 campaign.
The CDC has highlighted the following as the present trends; wastewater sampling of the COVID-19 virus, Emergency Department visits and the percent positive lab tests.
According to CDC modeled estimates, COVID-19 illness will increase in the coming weeks, as it is largely seasonal with cases mainly reported during the winter, the CDC noted.
According to CDC for RSV emergency department visits and hospitalizations are on the rise for children while it is also rising hospitalization in elderly in some regions.
While both flu and COVID-19 vaccines are authorized for use for both children and adults, there are specific RSV vaccines for certain groups of adults. However, vaccination coverage remains low; thus, a number of children and adults, as stated by the CDC, get little protection from respiratory virus infections by vaccines.
As of Dec. 21, 41.9% of adults were vaccinated with the flu shot and 21.4% with the new COVID-19 shot for the 2024-25 season. Moreover, CDC numbers state that only 43.7% of adults who are 75 years old or may extreme geriatric age have taken the RSV vaccine.
